Genmab A (GMAB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GMAB Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Genmab A finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents1,715.00
Cash & Short-term Investments1,715.00
Accounts receivable96.00
Trade & Other Current Receivables (IFRS combined total)1,112.00
Inventories2.83
Inventories18.00
Other Current Assets0.00
Total Current Assets2,885.00
Equipment/Property/Plant Net153.00
Goodwill net355.00
Intangible Assets9,123.00
Other Assets, Noncurrent1,410.17
Total Assets12,873.00
Liabilities
Longterm Borrowings5,001.00
Other Liabilities, Current0.00
Total Current Liabilities1,427.00
Total Long-term Debt0.00
Deferred Tax Liabilities, Net LI364.00
Other liabilities, Noncurrent1,661.00
Total Liabilities7,026.00
Stockholders' Equity
Other Equity5,713.00
Common Stockholder's Equity918.76
Total Stockholder's Equity5,847.00
Liabilities & Stockholder's Equity12,873.00
4 historic quarters locked

Sign in to unlock the full Genmab A balance sheet history.

About Genmab A s Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001434265-26-000014

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI